Schultes Birgit C

Schultes Birgit C is listed in filings as EVP at Intellia Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 3, 2026, including sale activity. Recent filings connect the profile to Intellia Therapeutics, Inc. (NTLA). The current snapshot covers public activity from Mar 4, 2025 to Mar 3, 2026. Reported amounts are shown as $771.7K to $539. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.